ClinVar Miner

Submissions for variant NM_001243133.2(NLRP3):c.906C>T (p.Phe302=)

gnomAD frequency: 0.00011  dbSNP: rs756989752
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001721371 SCV000531641 likely benign not provided 2019-09-09 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000429880 SCV000966483 likely benign not specified 2017-08-23 criteria provided, single submitter clinical testing p.Phe304Phe in exon 5 of NLRP3: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 1/8632 East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs756989752).
Labcorp Genetics (formerly Invitae), Labcorp RCV000876657 SCV001019255 likely benign Cryopyrin associated periodic syndrome 2023-11-07 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004533094 SCV004723923 likely benign NLRP3-related disorder 2019-08-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.